CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss and comprehensive loss	$ (41,704)	$ (122,404)	$ (187,952)
Adjustments to reconcile net loss to net cash provided by operating activities
Loss on impairments and disposal of assets	2,584	5,437	6,590
Amortization of intangibles	5,889	7,694	25,306
Depreciation	18,300	19,070	20,095
Non-cash compensation expense	28,579	39,682	59,624
Deferred income taxes	2,793	(4,692)	132,666
Bad debt expense	171	1,752	4,101
Amortization of debt issuance costs	2,168	3,137	6,432
Amortization of debt discount	331	0	1,475
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities	(2,839)	(4,404)	(1,547)
Gain on settlement of convertible debt	(9,035)	(48,562)	0
Loss (gain) on investments	58,376	114,504	0
Loss on impairment of goodwill	0	38,600	0
Changes in current assets and liabilities:
Accounts receivable	(43,007)	27,706	9,143
Prepaid and other current assets	(4,747)	(2,977)	(4,313)
Accounts payable, accrued expenses and other current liabilities	44,581	(5,541)	(28,418)
Income taxes receivable	96	(140)	214
Other, net	(278)	(1,291)	(449)
Net cash provided by operating activities	62,258	67,571	42,967
Cash flows from investing activities
Capital expenditures	(11,220)	(12,528)	(11,443)
Purchase of equity investment	0	0	(16,440)
Other investing activities	2	50	7
Net cash used in investing activities	(11,218)	(12,478)	(27,876)
Cash flows from financing activities
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options	(2,186)	(1,088)	(3,411)
Purchase of treasury stock	0	0	(43,009)
Proceeds from term loan	125,000	0	250,000
Repayment of term loan	(12,500)	(1,875)	(1,250)
Payment of debt issuance costs	(4,300)	(1,580)	(135)
Payment of original issue discount on term loan	(3,125)	0	0
Other financing activities	(552)	1	0
Net cash (used in) provided by financing activities	(56,502)	(242,006)	32,536
Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents	(5,462)	(186,913)	47,627
Cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period	112,056	298,969	251,342
Cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period	106,594	112,056	298,969
Non-cash investing activities:
Increase (decrease) in capital expenditures included in accounts payable and accrued expenses	128	(377)	(294)
Supplemental cash flow information:
Interest paid	38,203	23,685	19,017
Income tax payments	1,676	1,283	404
Income tax refunds	220	100	287
2025 Convertible Notes
Adjustments to reconcile net loss to net cash provided by operating activities
Amortization of debt issuance costs	1,000	2,200	3,000
Gain on settlement of convertible debt	(10,100)	(53,300)
Cash flows from financing activities
Repayment of Convertible Senior Notes	(158,839)	(237,464)	0
2022 Convertible Notes
Adjustments to reconcile net loss to net cash provided by operating activities
Amortization of debt issuance costs			400
Cash flows from financing activities
Repayment of Convertible Senior Notes	$ 0	$ 0	$ (169,659)